Cargando…
Tigecycline treatment in a liver transplant infant with carbapenem-resistant Escherichia coli infection: Case report
INTRODUCTION: During the past decade, the rate of carbapenem resistance among Enterobacteriaceae, mostly in Escherichia coli and Klebsiella pneumoniae, has significantly increased worldwide. It is a great challenge for the choice of drug treatment especially in children. Tigecycline is the first dru...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775363/ https://www.ncbi.nlm.nih.gov/pubmed/31574872 http://dx.doi.org/10.1097/MD.0000000000017339 |